Get Premium to unlock powerful stock data
NAS:GLPG (Belgium)  
Galapagos NV logo

Galapagos NV

$ 55.91 +0.11 (+0.2%) 12:16 PM EST
P/E:
At Loss
P/B:
1.32
Market Cap:
$ 3.67B
Enterprise V:
$ -1.18B
Volume:
117.66K
Avg Vol (2M):
281.16K
Also Trade In:
Volume:
117.66K
Market Cap $:
3.67B
PE Ratio:
At Loss
Avg Vol (2-Month):
281.16K
Enterprise Value $:
-1.18B
PB Ratio:
1.32
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
Name Current Vs Industry Vs History
Cash-To-Debt 183.14
Equity-to-Asset 0.52
Debt-to-Equity 0.01
Debt-to-EBITDA -0.73
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.8
Distress
Grey
Safe
Beneish M-Score -2.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.46
9-Day RSI 53
14-Day RSI 49.66
6-1 Month Momentum % -0.22
12-1 Month Momentum % -20.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.44
Quick Ratio 8.41
Cash Ratio 8.25
Days Inventory 1612.58
Days Sales Outstanding 71.83
Days Payable 12047.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.4

Financials (Next Earnings Date:2022-08-04)

GLPG's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GLPG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 582.771
EPS (TTM) ($) -2.284
Beta 0.2
Volatility % 34.88
14-Day RSI 49.66
14-Day ATR ($) 1.713036
20-Day SMA ($) 55.3515
12-1 Month Momentum % -20.15
52-Week Range ($) 46.41 - 72.11
Shares Outstanding (Mil) 65.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galapagos NV Filings

Document Form Filing Date
No Filing Data

Headlines

See More